Evidence map›Paper›PMID 35048195›Full record

ArticleMedical molecular morphology2022

Fascin expression persists with fibronectin in embryonic rat hepatoblasts.

Yoshihiro Hayashi, Yumiko Yamamoto, Ichiro Murakami

Abstract read
PubMed Publisher
In one paragraph

Article in Medical molecular morphology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yoshihiro HayashiEquipment of Support Planning Office, Kochi University, 185-1, Oko-cho, Kohasu, Nankoku, Kochi, 783-8505, Japan.
Yumiko YamamotoDepartment of Diagnostic Pathology, Kochi University Hospital, 185-1, Oko-cho, Kohasu, Nankoku, Kochi, 783-8505, Japan. yumi.esther.yamamoto@gmail.com.ORCID http://orcid.org/0000-0001-8585-6139
Ichiro MurakamiDepartment of Diagnostic Pathology, Kochi University Hospital, 185-1, Oko-cho, Kohasu, Nankoku, Kochi, 783-8505, Japan.
Kōchi University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Both fascin and fibronectin are known to play important roles in cell adhesion and migration. They are noted as tumor markers or inhibiting target for tumor treatment. In this study, embryonic rat livers were obtained to examine the expression of fascin and fibronectin during liver development. Then, the effect of fibronectin on fascin expression was investigated. At embryonic day (ED) 10.5, when the foregut endoderm began to form the liver bud and spread into the septum transversum, fibrous extracellular matrix was observed between the space where the liver bud and the septum transversum merged. At ED11.5, fibronectin was observed surrounding the cluster of fascin-positive hepatoblasts. At ED13.5, hematopoietic cells emerged and both fibronectin and fascin expression started to decline. Fascin and fibronectin appeared temporarily and disappeared by ED 14.5. Their expression was chronologically synchronized. Subsequently, the effect of fibronectin on fascin was examined by cultivation of hepatoblasts that were isolated from the ED13.5 rat liver. As a result, with fibronectin, fascin was positive in most hepatoblasts, although, without fibronectin, fascin expression was remarkably declined. Presently, there are few studies about the relationship between fascin and fibronectin. Our findings suggest that fibronectin could regulate fascin expression in rat hepatoblasts.

Indexed as

FibronectinsLiverAnimalsCarrier ProteinsCell AdhesionExtracellular MatrixMicrofilament ProteinsRatsCarrier ProteinsfascinFibronectinsMicrofilament ProteinsE-cadherinEmbryonic rat liverFascinFibronectinHepatoblasts

Identifiers

PMID35048195
OpenAlexW4206575248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.